[July 11, 2014] |
 |
Great Success for the First Edition of "French Life Sciences Days"
PARIS --(Business Wire)--
France
Biotech, (www.france-biotech.org),
an association of entrepreneurs in the life sciences industry, today
announced the high level of interest in the first edition of "French
Life Sciences Days" on June 25th and 26th in New
York and is pleased to announce the event renewal next year on June 17th
and 18th in New York.
This brand new initiative allowed 19 Life Sciences companies, recently
listed or more mature, with a market capitalization from Euro 25 to 477
million, developing Biotech and Medtech breakthrough technologies with
advanced clinical results or sales. Their CEOs have displayed their
business plans to 50 American non-specialized and specialized financial
investors.
Our firms' investment opportunities have attracted prestigious names of
Finance from Boston, New York and Philadelphia. These investors showed a
tremendous interest in the 19 inovative companies during 70 one-to-one
meetings (about 4 meetings per company).
This first edition has
also been broadly covered in French and American media (Forbes, The Wall
Street Journal: http://on.wsj.com/1wBk3UW,
Reuters (News - Alert), Les Echos, La Tribune, and a specific coverage from BFM
Business).
"The Life Sciences Days are a major element in promoting and
reinforcing the whole innovative SMEs funding scene, from startup to
more mature companies. Our goal has been achieved: French innovation in
the healthcare field has been recognized in the United States and the
investors are convinced that world future champions are among us! The
French financial players confirm Euronext's leading position. This
event's success calls for further ones and we will renew this event on
June 17th and 18th
2015 in New York and already plan the same initiative in Asia. I
particularly thank our sponsors, Bryan Garnier & Co, Société Générale,
Invest Securities, Deloitte (News - Alert), Mazars and NewCap who have been key to this
success!", Pierre-Olivier Goineau, the president of France Biotech,
said.
About the "French Life Sciences Days" This new initiative by
France Biotech aims at fostering and boosting the connections between
French public companies and investors worldwide in an effort to
facilitate exchanges and demonstrate the solidity of our own financial
community. The first edition will be held in New York. This "French Life
Sciences Days" initiative brings together key Parisian players (banks,
brokers, analysts, auditors, lawyers and communication agencies) to form
a sponsorship committee that will support entrepreneurs in the life
sciences. During this occasion, the French biotech and medtech companies
listed on the NYSE Euronext exchange will introduce themselves to
international investors.
About France Biotech France Biotech brings together the main
French life science companies and their expert partners. Its mission is
to support the development of the French life sciences by advocating for
a favorable regulatory and fiscal environment. In 2004, France Biotech
successfully lobbied the French government to create a special fiscal
status for innovative start-ups and continues to act as an advocate for
the French innovative sector. The organization is currently chaired by
Pierre-Olivier Goineau, Co-Founder and CEO of ERYTECH Pharma. France
Biotech has over 150 members and its board of directors is composed of
20 entrepreneurs in the life sciences.

[ Back To TMCnet.com's Homepage ]
|